Consistently, another study indicated that a 12-week CT intervention increased circulating irisin and follistatin (FST) while decreasing MSTN (Rad et al., 2023) in patients with T2DM (Rad et al., 2023). The gene discussed is MSTN; the disease is type 2 diabetes mellitus.